10th RSC-BMCS Fragment-based Drug Discovery Meeting

Meet Novalix at 10th RSC-BMCS Fragment-based Drug Discovery Meeting in Cambridge, UK, from September 14 to 16, 2026.

The RSC-BMCS Fragment-based Drug Discovery meeting will focus on case studies in Fragment-based Drug Discovery that have delivered compounds to late stage medicinal chemistry, preclinical or clinical programmes.
The Fragment series started in 2007 and continues with this theme in having over three-quarters of the presentations focused on case studies. This will be complemented by technology progress in high concentration, NMR, SPR and X-ray screening.

NMR for Fragment-Based Drug Discovery: AI-Accelerated Structure Determination with NMRtist and the NovaFrag™ 2.0 Library – From Bcl-xL Benchmarking to Real Case Study

We are proud to share that Dr Marc Vitorino, Head of NMR, Biophysics, will present a scientific poster at the event. He will showcase how AI-powered NMR structure determination is advancing fragment-based drug discovery, from benchmark validation to real-world applications.

Novalix Booth No. 16

Connect with Dr Thomas Flower, Manager Business Development, and Dr Vitorino on our booth No. 16 to discover more about our expertise and capabilities in Biophysics, Pharmacology and DMPK, Chemistry, and Drug Discovery.